Due to the lack of randomized prospective clinical trials, there is no strong evidence in the literature to support macular translocation as an effective treatment for neovascular ARMD.

To date, only PDT with the photosensitizer verteporfin has been proven to decrease the risk of visual loss in patients with neovascular ARMD. Thus, this section will be limited to this form of ...

Neovascular glaucoma is a vision-threatening eye condition. It’s characterized by new blood vessel growth over your iris and the area where fluid drains from your eye. Glaucoma is a group of ...